Clearside Biomedical Stock Today
| CLSD Stock | USD 1.37 0.04 2.84% |
Performance4 of 100
| Odds Of DistressOver 80
|
Clearside Biomedical is trading at 1.37 as of the 24th of April 2024, a -2.84 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.35. Clearside Biomedical has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Clearside Biomedical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 2nd of June 2016 | Category Healthcare | Classification Health Care |
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia. The company has 74.72 M outstanding shares of which 224.27 K shares are currently shorted by private and institutional investors with about 0.33 trading days to cover. More on Clearside Biomedical
Moving together with Clearside Stock
| 0.72 | BMY | Bristol Myers Squibb Earnings Call Tomorrow | PairCorr |
Moving against Clearside Stock
| 0.45 | ZURA | Zura Bio Limited Financial Report 10th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 9th of May 2024
Clearside Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Clearside Biomedical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Clearside Biomedical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO, Director | Daniel White | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation Analysts covering Clearside Biomedical report their recommendations after researching Clearside Biomedical's financial statements, talking to executives and customers, or listening in on Clearside Biomedical's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Clearside Biomedical. The Clearside consensus assessment is calculated by taking the average forecast from all of the analysts covering Clearside Biomedical. | |||||
Clearside Biomedical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Clearside Biomedical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Clearside Biomedical's financial leverage. It provides some insight into what part of Clearside Biomedical's total assets is financed by creditors.
| |||||
Clearside Biomedical (CLSD) is traded on NASDAQ Exchange in USA. It is located in 900 North Point Parkway, Alpharetta, GA, United States, 30005 and employs 30 people. Clearside Biomedical is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 103.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Clearside Biomedical's market, we take the total number of its shares issued and multiply it by Clearside Biomedical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Clearside Biomedical conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 74.72 M outstanding shares of which 224.27 K shares are currently shorted by private and institutional investors with about 0.33 trading days to cover.
Clearside Biomedical currently holds about 29.03 M in cash with (18.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48.
Check Clearside Biomedical Probability Of Bankruptcy
Ownership AllocationClearside Biomedical holds a total of 74.72 Million outstanding shares. Clearside Biomedical shows 7.29 percent of its outstanding shares held by insiders and 21.23 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Clearside Ownership Details
Clearside Stock Price Odds Analysis
What are Clearside Biomedical's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Clearside Biomedical jumping above the current price in 90 days from now is about 58.79%. The Clearside Biomedical probability density function shows the probability of Clearside Biomedical stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.6398 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Clearside Biomedical will likely underperform. Additionally, clearside Biomedical has an alpha of 0.1103, implying that it can generate a 0.11 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Clearside Biomedical to move above the current price in 90 days from now is about 58.79 (This Clearside Biomedical probability density function shows the probability of Clearside Stock to fall within a particular range of prices over 90 days) .
Clearside Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Clearside Biomedical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Clearside Biomedical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Clearside Biomedical's value.| Instituion | Recorded On | Shares | |
| Northeast Financial Consultants, Inc | 2023-12-31 | 93 K | |
| Northern Trust Corp | 2023-12-31 | 91.8 K | |
| Susquehanna International Group, Llp | 2023-12-31 | 90.1 K | |
| Synovus Financial Corp | 2023-12-31 | 53.1 K | |
| Captrust Financial Advisors | 2023-12-31 | 50 K | |
| Natixis Sa | 2023-12-31 | 47.5 K | |
| Banque Cantonale Vaudoise | 2023-12-31 | 40 K | |
| Stifel Financial Corp | 2023-12-31 | 34 K | |
| Millennium Management Llc | 2023-12-31 | 33.6 K | |
| Vanguard Group Inc | 2023-12-31 | 2.2 M | |
| Carmignac Gestion | 2023-12-31 | 2.1 M |
Clearside Biomedical Historical Income Statement
Clearside Biomedical Income Statement is one of the three primary financial statements used for reporting Clearside's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Clearside Biomedical revenue and expense. Clearside Biomedical Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Clearside Biomedical's Other Operating Expenses is projected to increase significantly based on the last few years of reporting. The current year's Research Development is expected to grow to about 24.9 M, whereas Operating Income is forecasted to decline to (26.1 M). View More FundamentalsClearside Stock Against Markets
Picking the right benchmark for Clearside Biomedical stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Clearside Biomedical stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Clearside Biomedical is critical whether you are bullish or bearish towards Clearside Biomedical at a given time. Please also check how Clearside Biomedical's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Clearside Biomedical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Clearside Biomedical Corporate Directors
Clearside Biomedical corporate directors refer to members of a Clearside Biomedical board of directors. The board of directors generally takes responsibility for the Clearside Biomedical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Clearside Biomedical's board members must vote for the resolution. The Clearside Biomedical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Jeffrey Edwards | Director | Profile | |
| William Humphries | Director | Profile | |
| Clay Thorp | Director | Profile | |
| Derek Yoon | Independent Director | Profile |
How to buy Clearside Stock?
Before investing in Clearside Biomedical, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Clearside Biomedical. To buy Clearside Biomedical stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Clearside Biomedical. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Clearside Biomedical stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Clearside Biomedical stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Clearside Biomedical stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Clearside Biomedical, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Clearside Stock please use our How to Invest in Clearside Biomedical guide.
Already Invested in Clearside Biomedical?
The danger of trading Clearside Biomedical is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Clearside Biomedical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Clearside Biomedical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Clearside Biomedical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Clearside Biomedical is a strong investment it is important to analyze Clearside Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clearside Biomedical's future performance. For an informed investment choice regarding Clearside Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearside Biomedical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Clearside Stock analysis
When running Clearside Biomedical's price analysis, check to measure Clearside Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearside Biomedical is operating at the current time. Most of Clearside Biomedical's value examination focuses on studying past and present price action to predict the probability of Clearside Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearside Biomedical's price. Additionally, you may evaluate how the addition of Clearside Biomedical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Clearside Biomedical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearside Biomedical. If investors know Clearside will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearside Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.53) | Revenue Per Share 0.133 | Quarterly Revenue Growth 18.227 | Return On Assets (0.36) | Return On Equity (13.10) |
The market value of Clearside Biomedical is measured differently than its book value, which is the value of Clearside that is recorded on the company's balance sheet. Investors also form their own opinion of Clearside Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Clearside Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearside Biomedical's market value can be influenced by many factors that don't directly affect Clearside Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearside Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearside Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearside Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.